Breaking News

Kiniksa Pharmaceuticals Ltd (KNSA)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

25.23 +0.74 +3.02%

15:59:59 - Closed. Currency in USD ( Disclaimer )

After Hours

24.80

-0.43

-1.70%

16:20:26 - Real-time Data

Type: Equity

Market: United States

Volume: 265,174
Bid/Ask: 0.00 / 0.00
Day's Range: 24.79 - 26.14

Discussions
Recent Sentiments
User Rankings

KNSA Recent Sentiments

This page contains information on users’ sentiments for the Kiniksa Pharmaceuticals Ltd stock, which are displayed both on charts of different periods of time and on a detailed table.

Start Date	Username	Open Rate	End Date	Chg. %
Aug 01, 2024	Gina Palladino	26.81	Aug 05, 2024 @ 24.28	-9.44%
Jan 08, 2024	Aleene Brown	18.38	Feb 02, 2024 @ 18.38	0.00%
Jan 04, 2024	Sutrisno Adi	18.22	Jan 26, 2024 @ 18.22	0.00%
Dec 28, 2023	עמי וינברג	18.21	Jan 01, 2024 @ 17.54	-3.68%
Jul 25, 2023	Marco Zanetti	19.47	Jul 25, 2023 @ 19.25	+1.13%
Jul 25, 2023	Claudio Santoro	18.97	Nov 30, 2023 @ 15.82	-16.61%
Jul 14, 2023	Bas van der Meij	13.92	Nov 30, 2023 @ 15.82	+13.65%
Jun 26, 2023	aidan lambert	14.86	Nov 30, 2023 @ 15.82	+6.46%
Aug 24, 2022	احمد الغامدي	12.55	Aug 29, 2022 @ 11.86	-5.50%
Aug 04, 2022	IBRAHIM Alotibi	11.68	Aug 26, 2022 @ 12.22	+4.62%
Aug 03, 2022	Abdulaziz Alanazi	10.69	Aug 26, 2022 @ 12.22	+14.31%
Aug 03, 2022	Davide Carraro	11.03	Aug 26, 2022 @ 12.22	+10.79%
Dec 28, 2021	Freddy De Meersman	12.33	Jan 21, 2022 @ 10.37	-15.90%
Sep 14, 2021	Davide Carraro	12.04	Oct 08, 2021 @ 11.19	-7.06%
Jul 26, 2021	Davide Carraro	14.07	Aug 20, 2021 @ 12.20	-13.29%
Jul 01, 2021	Ashish Sheth	14.08	Jul 23, 2021 @ 14.50	-2.98%
Jul 01, 2021	Ashish Sheth	14.08	Jul 23, 2021 @ 14.50	+2.98%
Jun 21, 2021	Ling Tin Ko	14.38	Jun 21, 2021 @ 14.38	0.00%
Jun 08, 2021	Davide Carraro	13.88	Jul 02, 2021 @ 14.08	+1.44%
Apr 15, 2021	Aigerim Adilbekova	16.35	May 07, 2021 @ 14.63	-10.52%
Apr 15, 2021	Hizami Aziz	16.71	Apr 19, 2021 @ 15.15	-9.34%
Mar 23, 2021	Monika Moeun	18.73	Apr 16, 2021 @ 15.63	-16.55%
Mar 22, 2021	Monika Moeun	19.20	Mar 23, 2021 @ 18.73	+2.45%
Mar 19, 2021	Ben Crooke	20.69	Mar 20, 2021 @ 20.14	-2.66%
Mar 17, 2021	Nicholas Teo	22.32	Apr 09, 2021 @ 17.69	-20.74%
Mar 15, 2021	eugene emory	23.45	Apr 09, 2021 @ 17.69	-24.56%
Mar 09, 2021	Oscar Gigs	22.46	Mar 15, 2021 @ 23.00	+2.40%
Feb 22, 2021	Ashish Sheth	24.25	Mar 19, 2021 @ 20.14	-16.95%
Feb 22, 2021	Ashish Sheth	24.25	Mar 19, 2021 @ 20.14	-16.95%
Sep 15, 2020	Heino Entzeroth	17.64	Oct 09, 2020 @ 20.95	+18.76%
Aug 27, 2020	Jose Gomez Rial	16.25	Sep 18, 2020 @ 17.24	+6.09%
Jul 27, 2020	Aryan sheth	20.20	Aug 21, 2020 @ 17.64	+12.67%
Jul 27, 2020	Jose Gomez Rial	20.32	Aug 08, 2020 @ 19.70	-3.05%
Jul 21, 2020	Yair Berdugo	21.89	Aug 14, 2020 @ 17.70	-19.14%
Jul 16, 2020	Jose Gomez Rial	21.99	Jul 27, 2020 @ 20.32	+7.59%
Jul 09, 2020	Jose Gomez Rial	24.12	Jul 16, 2020 @ 21.99	-8.83%
May 21, 2020	Andreas Schatz	21.84	Jun 12, 2020 @ 21.52	-1.47%
May 13, 2020	G BHARATH SIMHA REDDY	19.75	Jun 05, 2020 @ 21.55	+9.11%
May 01, 2020	Jose Gomez Rial	19.16	May 22, 2020 @ 21.44	+11.90%
Apr 23, 2020	Andreas Schatz	20.56	May 15, 2020 @ 21.46	+4.38%
Apr 22, 2020	Cristián Villanueva	20.40	May 15, 2020 @ 21.46	+5.20%
Feb 04, 2020	Lorenzo Dagna	15.71	Feb 28, 2020 @ 18.46	+17.50%
Jan 09, 2020	Gabriel Gamboa	14.04	Jan 31, 2020 @ 14.71	+4.77%
Dec 10, 2019	mario shannon	14.50	Jan 03, 2020 @ 12.25	+15.52%
Nov 22, 2019	vbg99	8.94	Nov 25, 2019 @ 9.62	+7.61%
Nov 20, 2019	davide garulli	9.00	Dec 13, 2019 @ 12.57	-39.67%
Jul 09, 2019	Robbert Kuipers	15.79	Aug 02, 2019 @ 11.36	-28.06%
Dec 11, 2018	Fl Fa	24.64	Jan 10, 2019 @ 0.00	+100.00%
Dec 04, 2018	Angel Fernandez	20.77	Jan 03, 2019 @ 0.00	+100.00%
Nov 28, 2018	Nick_Sai	21.36	Dec 28, 2018 @ 0.00	-100.00%

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

KNSA Comments

Write your thoughts about Kiniksa Pharmaceuticals Ltd

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Stephen Appiah Mar 19, 2021 9:28AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

I'm surprised no activity there is little activity on this stock.

1 0

Report

ArlN Mar 18, 2021 5:15PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

The FDA has approved. - ARCALYST is the first and only FDA-approved therapy for recurrent pericarditis- Commercial launch expected in April 2021- Kiniksa launches Kiniksa One Connect™ patient support program

0 0

Report

ArlN Mar 15, 2021 6:26PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Breakthrough Therapy designation granted by the FDA for rilonacept for the treatment of recurrent pericarditis, due date is 21st March 2021 under priority review.That should help some movement

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="221833712">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="221833712" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="221833712" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="221833712">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	41,395.0	+298.2	+0.73%
US 500	5,622.6	+26.8	+0.48%
Dow Jones	41,393.78	+297.01	+0.72%
S&P 500	5,626.02	+30.26	+0.54%
Nasdaq	17,681.55	+111.88	+0.64%
S&P 500 VIX	16.56	-0.51	-2.99%
Dollar Index	101.105	-0.246	-0.24%

Crude Oil WTI	69.24	+0.27	+0.39%
Brent Oil	72.18	+0.21	+0.29%
Natural Gas	2.294	-0.063	-2.67%
Gold	2,606.20	+25.60	+0.99%
Silver	31.065	+0.958	+3.18%
Copper	4.2210	+0.0255	+0.61%
US Soybeans	1,006.50	-4.50	-0.45%

U.S. 10Y	3.657	+0.008	+0.22%
U.S. 30Y	3.984	0.007	0.17%
U.S. 5Y	3.435	0.011	0.31%
U.S. 3M	4.903	0.000	0.00%
US 10Y T-Note	115.39	+0.20	+0.18%
Euro Bund	134.78	+0.05	+0.04%
10-2 Yield Spread	3.02	+2.09	+224.73%

Apple	222.50	-0.27	-0.12%
Alphabet A	157.46	+2.77	+1.79%
Tesla	230.29	+0.48	+0.21%
Amazon.com	186.49	-0.51	-0.27%
Netflix	697.10	+10.30	+1.50%
Meta Platforms	524.62	-0.98	-0.19%
Bank of America	38.65	-0.13	-0.34%

Recent Quotes

	Name	Price	Chg.	Chg. %
	KNSA	25.23	+0.74	+3.02%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	119.08	-0.05%	236.53M
TSLA	230.29	+0.21%	59.10M
AAPL	222.50	-0.12%	35.40M
AMZN	186.49	-0.27%	26.00M
MSFT	430.59	+0.84%	14.49M
ADBE	536.87	-8.47%	10.18M
META	524.62	-0.19%	9.79M

Name	Last	Chg. %	Vol.
WBD	8.49	+10.84%	57.64M
VFC	18.70	+8.47%	5.88M
ETSY	55.65	+7.56%	6.10M
ALGN	243.73	+6.50%	887.00K
UBER	72.48	+6.45%	30.03M
CZR	38.87	+6.41%	5.18M
ARM	147.37	+5.88%	10.80M

Name	Last	Chg. %	Vol.
ADBE	536.87	-8.47%	10.18M
GRMN	172.66	-5.14%	1.75M
BA	156.77	-3.69%	18.89M
NSC	245.80	-3.45%	2.37M
FSLR	228.79	-3.03%	2.16M
PDD	94.99	-2.40%	15.94M
MRNA	68.28	-2.01%	11.45M

Webinars

How To Beat 90% of Investors With Our 3-Step Screener Wednesday, September 25, 2024 | 08:00AM EDT